Adaptive Biotechnologies Corp
ADPT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001478320
In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 11 sales; 301 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.
Q2 2021 vs. Q1 2021
How the institutions holding Adaptive Biotechnologies Corp changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 249 | 231 | −18 |
| Shares | 113.8M | 117.4M | +3.64M (+3.2%) |
| Value | $4.58B | $4.80B | +$214.8M (+4.7%) |
New holders (38)
Institutions that held Adaptive Biotechnologies Corp at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (56)
Institutions that held Adaptive Biotechnologies Corp at the end of Q1 2021 and filed for Q2 2021 without it.